Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Description

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Conditions

Opioid Use

Talk to us

Study Overview

On this page

Study Details

Study overview

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Condition
Opioid Use
Intervention / Treatment

-

Contacts and Locations

Baltimore

Division of Parole & Probation, Baltimore, Maryland, United States, 21202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Subject must provide written informed consent prior to the conduct of any study-related procedures
  • 2. Male or female, 18-65 years of age, inclusive
  • 3. Be on parole or probation for at least the next 4 months
  • 4. Have a Baltimore City address, and (5) Primary diagnosis of (DSM-5) moderate-severe opioid use disorder (at least 4 symptoms) including current use and current physiologic dependence \[Note: parolees not currently physically dependent will be allowed in the study\].
  • 1. Current medical condition that may prevent the participant from safely participating in the study as determined by medical evaluation
  • 2. Current psychosis or suicidal ideation
  • 3. Cognitive disorders that prevent the participant from passing a study enrollment quiz
  • 4. Any pending legal action that would interrupt study participation (eg, pending incarceration, probation/parole revocation, unadjudicated charges)
  • 5. Exposure to any investigational drug within 8 weeks of screening
  • 6. Current use benzodiazepines (such as Valium, Xanax and other sedatives), either prescribed or illicitly obtained
  • 7. Currently enrolled in a methadone maintenance treatment program or taking long-acting naltrexone.

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Friends Research Institute, Inc.,

Study Record Dates

2026-06-30